| Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. R Göke, HC Fehmann, T Linn, H Schmidt, M Krause, J Eng, B Göke Journal of Biological Chemistry 268 (26), 19650-19655, 1993 | 1069 | 1993 |
| Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man R Eissele, R Göke, S Willemer, HP Harthus, H Vermeer, R Arnold, B Göke European journal of clinical investigation 22 (4), 283-291, 1992 | 847 | 1992 |
| Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients C Herrmann, R Göke, G Richter, HC Fehmann, R Arnold, B Göke Digestion 56 (2), 117-126, 1995 | 829 | 1995 |
| Glucagon-like peptide-1: a potent regulator of food intake in humans JP Gutzwiller, B Göke, J Drewe, P Hildebrand, S Ketterer, D Handschin, ... Gut 44 (1), 81-86, 1999 | 753 | 1999 |
| Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide HC Fehmann, R Göke, B Göke Endocrine reviews 16 (3), 390-410, 1995 | 718 | 1995 |
| Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2 JP Gutzwiller, J Drewe, B Göke, H Schmidt, B Rohrer, J Lareida, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 1999 | 717 | 1999 |
| IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration S Brand, F Beigel, T Olszak, K Zitzmann, ST Eichhorst, JM Otte, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 290 (4 …, 2006 | 707 | 2006 |
| International Union of Pharmacology. XXXV. The glucagon receptor family KE Mayo, LJ Miller, D Bataille, S Dalle, B Göke, B Thorens, DJ Drucker Pharmacological reviews 55 (1), 167-194, 2003 | 645 | 2003 |
| Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men JP Gutzwiller, S Tschopp, A Bock, CE Zehnder, AR Huber, M Kreyenbuehl, ... The Journal of Clinical Endocrinology & Metabolism 89 (6), 3055-3061, 2004 | 536 | 2004 |
| Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Schirra, M Katschinski, C Weidmann, T Schäfer, U Wank, R Arnold, ... The Journal of clinical investigation 97 (1), 92-103, 1996 | 534 | 1996 |
| Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population A Graser, P Stieber, D Nagel, C Schaefer, D Horst, CR Becker, K Nikolaou, ... Gut 58 (2), 241-248, 2009 | 498 | 2009 |
| Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis M Lehrke, A Becker, M Greif, R Stark, RP Laubender, F von Ziegler, ... European journal of endocrinology 161 (2), 339-344, 2009 | 477 | 2009 |
| Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p … J Seiderer, I Elben, J Diegelmann, J Glas, J Stallhofer, C Tillack, ... Inflammatory bowel diseases 14 (4), 437-445, 2008 | 474 | 2008 |
| Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes: importance of postprandial glycemia to achieve target HbA1c levels HJ Woerle, C Neumann, S Zschau, S Tenner, A Irsigler, J Schirra, ... Diabetes research and clinical practice 77 (2), 280-285, 2007 | 444 | 2007 |
| Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis FT Kolligs, G Bommer, B Göke Digestion 66 (3), 131-144, 2002 | 439 | 2002 |
| Glucose-dependent insulinotropic polypeptide is a growth factor for β (INS-1) cells by pleiotropic signaling A Trümper, K Trümper, H Trusheim, R Arnold, B Göke, D Hörsch Molecular endocrinology 15 (9), 1559-1570, 2001 | 379 | 2001 |
| Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans J Schirra, M Nicolaus, R Roggel, M Katschinski, M Storr, HJ Woerle, ... Gut 55 (2), 243-251, 2006 | 352 | 2006 |
| Exendin (9-39) amide is an antagonist of glucagon-like peptide-1 (7-36) amide in humans. J Schirra, K Sturm, P Leicht, R Arnold, B Göke, M Katschinski The Journal of clinical investigation 101 (7), 1421-1430, 1998 | 346 | 1998 |
| The role of the novel Th17 cytokine IL-26 in intestinal inflammation J Dambacher, F Beigel, K Zitzmann, EN De Toni, B Göke, HM Diepolder, ... Gut 58 (9), 1207-1217, 2009 | 316 | 2009 |
| Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1 (7–36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like … K Hupe-Sodmann, GP McGregor, R Bridenbaugh, R Göke, B Göke, ... Regulatory peptides 58 (3), 149-156, 1995 | 291 | 1995 |